Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs Sufentanil for Postoperative Analgesia in Knee Replacement
NCT06668298Not yet recruiting
- Sponsor
- Henan Provincial People's Hospital
- Start
- Nov 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
01
Overview
Randomised trial of oliceridine in postoperative pain (2 arms), sponsored by Henan Provincial People's Hospital. Primary endpoint: Total Pain Intensity Difference within 48 Hours. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06668298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06668298.